These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8054692)

  • 1. [Ultrastructural and immunohistochemical study of the olfactory mucosa in Alzheimer's disease].
    Brouillard M; Laccourreye L; Jabbour W; Emile J; Pouplard-Barthelaix A
    Bull Assoc Anat (Nancy); 1994 Mar; 78(240):25-8. PubMed ID: 8054692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Olfactory mucosa and Alzheimer's disease. Technique for biopsy and ultrastructural study].
    Laccourreye L; Brouillard M; Emile J; Pouplard-Barthelaix A
    Ann Otolaryngol Chir Cervicofac; 1991; 108(5):277-85. PubMed ID: 1759743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
    Norès JM; Biacabe B; Bonfils P
    Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological changes in olfactory neurons in patients with Alzheimer's disease.
    Talamo BR; Rudel R; Kosik KS; Lee VM; Neff S; Adelman L; Kauer JS
    Nature; 1989 Feb; 337(6209):736-9. PubMed ID: 2465496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of olfactory mucosa in patients with Alzheimer's disease.
    Yamagishi M; Ishizuka Y; Seki K
    Ann Otol Rhinol Laryngol; 1994 Jun; 103(6):421-7. PubMed ID: 8203807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: increased immunoreactivity in Alzheimer's disease.
    Kulkarni-Narla A; Getchell TV; Schmitt FA; Getchell ML
    Exp Neurol; 1996 Aug; 140(2):115-25. PubMed ID: 8690055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-amyloid fibrils of Alzheimer's disease: pathologically altered, basement membrane-associated microfibrils?
    Inoue S; Kisilevsky R
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):93-102. PubMed ID: 11730002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of amyloid beta-protein deposits in extracerebral tissues of patients with Alzheimer's disease.
    Skodras G; Peng JH; Parker JC; Kragel PJ
    Ann Clin Lab Sci; 1993; 23(4):275-80. PubMed ID: 8373132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.
    Peacock ML; Murman DL; Sima AA; Warren JT; Roses AD; Fink JK
    Ann Neurol; 1994 Apr; 35(4):432-8. PubMed ID: 8154870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's neurofibrillary changes in the olfactory bulb in myotonic dystrophy.
    Yoshimura N
    Clin Neuropathol; 1990; 9(5):240-3. PubMed ID: 2272144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain biopsy prior to treatment of Alzheimer's disease.
    Holm A; Savolainen S; Alafuzoff I
    Minim Invasive Neurosurg; 2003 Jun; 46(3):161-4. PubMed ID: 12872193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of Alzheimer's?
    Kishikawa M; Iseki M; Sakae M; Kawaguchi S; Fujii H
    Nature; 1994 Jun; 369(6479):365-6. PubMed ID: 8196764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.